Skip to main navigation
Tactile Medical
  • About Lymphedema
    • Overview
    • Signs & Symptoms
    • Treatment
    • Management
  • Products
    • Overview
    • FLEXITOUCH® system
    • Entre™ System
    • Actitouch® System
    • Clinical Evidence
  • Patients
    • Overview
    • Signs & Symptoms
    • Patient Testimonials
    • Lymphedema Partners
  • Healthcare Professionals
    • Overview
    • Virtual Learning
    • Clinician Perspectives
    • Health Plan Coverage
    • Veterans Affairs
    • Clinical Evidence
    • Professional Affiliations
    • Educational Resources
  • Investors
    • News
    • Events & Webcasts
    • Stock Information
    • Annual Reports & SEC Filings
    • Corporate Governance
    • Investor FAQs
    • Investor Contacts
  • About Us
    • Who We Are
    • Leadership
    • News
    • Careers
Patient Portal
Select Page

News Release Details

Tactile Medical to Participate in Upcoming Investor Conferences in February and March

February 9, 2021 at 4:05 PM EST
PDF Version

MINNEAPOLIS, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that management will participate in the following upcoming investor conferences:

The BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

  • Management will participate in a virtual fireside chat on Wednesday, February 17 at 9:30 a.m. Eastern Time.

The Oppenheimer 31st Annual Healthcare Conference

  • Management will present on Tuesday, March 16 at 10:40 a.m. Eastern Time.

Audio webcasts of the presentations will be accessible under the “Events & Webcasts” section of the Company's investor relations website at http://investors.tactilemedical.com. The webcasts will be available for replay following the conferences.

About Tactile Medical

Tactile Medical is a leader in developing and marketing at-home therapy devices that treat chronic swelling conditions such as lymphedema and chronic venous insufficiency. Tactile Medical’s Mission is to help people suffering from chronic diseases live better and care for themselves at home. The Company’s unique offering includes advanced, clinically proven pneumatic compression devices, as well as continuity of care services provided by a national network of product specialists and trainers, reimbursement experts, patient advocates and clinicians. This combination of products and services ensures that tens of thousands of patients annually receive the at-home treatment necessary to better manage their chronic conditions. Tactile Medical takes pride in the fact that our solutions help increase clinical efficacy, reduce overall healthcare costs and improve the quality of life for patients with chronic conditions.


Investor Inquiries:
Mike Piccinino, CFA
Managing Director
Westwicke Partnersinvestorrelations@tactilemedical.com

Primary Logo

Source: Tactile Systems Technology, Inc.

  • RSS Feeds
  • Email Alerts
  • Investor Contacts
  • Print Page
  • E-mail Page
Logo


Tactile Systems Technology, Inc. BBB Business Review
  • About Lymphedema
  • Products
  • Patients
  • Healthcare Professionals
  • Investors
  • About Us
  • Careers
  • Pay My Bill
  • Educational Resources
  • Patient Contact Us
  • Clinician Contact Us
  • Forms
  • Media Resources
  • Privacy Statement
  • California Privacy Notice
  • Privacy Line: 833.382.2845 ext. 55211
  • Terms & Conditions
  • Warranty & Return Policies
3701 Wayzata Blvd, Suite 300
Minneapolis, MN 55416 USA

Phone: 612.355.5100
Toll-free: 866.435.3948
Fax: 866.435.3949
facebook linkedin twitter youTube
Flexitouch, Actitouch, Entre and HEALING RIGHT AT HOME are all trademarks or registered trademarks of Tactile Medical.
D/N500187-000-00 Rev. J 11/2017